Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-OakSHXrb
January 13, 2023jan-zheng

In a new GARDP antimicrobial viewpoint piece, Jon Iredell and Jessica Sacher of Phage Australia discuss ways to improve the economics of personalized phage therapy as part of a clinical service, including increasing the number of patients who benefit from each phage batch, establishing safety through endpoint rather than full process controls, and exploring new payment models like value-based pricing.
Opinion Phage economics
Loading ...
No comments yet. Be the first to comment!